| Title : Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis - Keeney_1997_Doc.Ophthalmol_93_125 |
| Author(s) : Keeney AH , Keeney VT |
| Ref : Doc Ophthalmol , 93 :125 , 1997 |
|
Abstract :
In an era when women were not admitted to the University of Edinburgh and when England's first female physician (Elizabeth Garrett Anderson, 1836-1917) had to venture to Paris, France, to earn her M.D. in 1870, the career of Mary Broadfoot Walker (Figure 1) (1988-1974) stands out for truly remarkable achievement. She is credited with making the most significant discovery in medical therapeutic within the British empire. |
| PubMedSearch : Keeney_1997_Doc.Ophthalmol_93_125 |
| PubMedID: 9476610 |
| Inhibitor | Neostigmine~Prostigmine |
Keeney AH, Keeney VT (1997)
Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis
Doc Ophthalmol
93 :125
Keeney AH, Keeney VT (1997)
Doc Ophthalmol
93 :125